SIMILAR RETINAL FINDINGS IN TRAUMATIC BRAIN INJURY AND ALZHEIMER’S
DOI:
https://doi.org/10.29121/granthaalayah.v6.i11.2018.1135Keywords:
Similar Retinal, Traumatic, Brain Injury, Alzheimer’sAbstract [English]
Aim: Our aim was to show similarities between retinal findings in Alzheimer’s disease (AD) and Traumatic Brain Injury (TBI).
Methods: 30 patients with AD, 4 patients with TBI and 20 age-matched healthy controls were examined by FAF and SD-OCT to find amyloid plaques and tau tangles in the retina.
Results: Similar images of plaques and tau tangles were detected in both diseases.
Conclusion: TBI may cause neurodegeneration in the retina similar to AD.
Downloads
References
Prince, M. And Bryce, R. And Ferri, C.: World Alzheimer Report 2011,. Alzheimer's Disease International, 2011
Hyman Bt, Phelps, Ch, Beach Tg, Bigio Eh, Cairns Nj, Carrillo Mc, Et Al. National Institute on Aging– Alzheimer’s: Association Guidelines on Neuropathology Assessment of Alzheimer’sdisease. Alzheimers Dement 2012:1–13. DOI: https://doi.org/10.1016/j.jalz.2011.10.007
Faden Ai, Loane Dj: Chronic Neurodegeneration after Traumatic Brain Injury. Neurotherapeutics. 12(1); 2015 DOI: https://doi.org/10.1007/s13311-014-0319-5
Mckee Ac, Robinson Me. Military-Related: Traumatic Brain Injury and Neurodegeneration. Alzheimers Dement. 2014, 10:242–53 DOI: https://doi.org/10.1016/j.jalz.2014.04.003
Barnes And Yaffe, K.: The Projected Effect of Risk Factor Reduction on Alzheimer's Disease Prevalence, the Lancet Neurology 10:819–828. 2011. DOI: https://doi.org/10.1016/S1474-4422(11)70072-2
Blennow, K. And Hampel, H.: Csf Markers For Incipient Alzheimer's Disease,. The Lancet Neurology 2:605–613. 2003 DOI: https://doi.org/10.1016/S1474-4422(03)00530-1
Terman A, Brunk Ut: Lipofuscin. Int J Biochem Cell Biol. 2004 Aug, 36:1400–4.
Seehafer Ss, Pearce Da. You Say Lipofuscin: We Say Ceroid: Defining Autofluorescent Storage Material Apr. 2006, 27:576–88. DOI: https://doi.org/10.1016/j.neurobiolaging.2005.12.006
Nandakumar N, Buzney S, Weiter Jj. Lipofuscin: And the Principles of Fundus Autofluorescence: A Review. Semin Ophthalmol. 2012 Sep-Nov, 27:197–201.
Maya Koronyo-Hamaoui, S. Yosef Koronyo, Alexander V. Ljubimov, Carol A. Miller, Minhee K. Ko, Keith L. Black Et Al. Identification: Amyloid Plaques in Retinas From Alzheimer’s Patients and Noninvasive In Vivo Optical Imaging Of Retinal Plaques In A Mouse Model. Neuroimage. 2011 January, 54:204. S217 DOI: https://doi.org/10.1016/j.neuroimage.2010.06.020
Bloudek Lm, Spackman Ed, Blankenburg M: Sullivan Sd.Review And Meta-Analysis Of Biomarkers And 55 Diagnostic Imaging In Alzheimer’s Disease. J Alzheimers. Dis, 2011:627– 45. DOI: https://doi.org/10.3233/JAD-2011-110458
Clinic, Mayo: Tau A Driver of Alzheimer's Disease, Study of Thousands of Brains Reveals. Sciencedaily. March 2015,
Ishizawa T, Mattila P, Davies P, Wang D, Dickson: Dw. Colocalization of Tau and Alphasynuclein Epitopes in Lewy Bodies. J Neuropathol Exp Neurol. 2003, 62:389–397. DOI: https://doi.org/10.1093/jnen/62.4.389
Simon Moussaud, Daryl R Jones, Elisabeth L: Moussaud-Lamodière. Alpha-Synuclein And Tau: Teammates In Neurodegeneration?. Molecular Neurodegeneration. 2014, 9:43 DOI: https://doi.org/10.1186/1750-1326-9-43
Badiola N, De Oliveira Rm, Herrera F, Guardia-Laguarta C, Goncalves Sa, Pera M:
Suarez-Calvet M, Clarimon J, Outeiro Tf, Leo A: Tau Enhances Alpha-Synuclein Aggregation And Toxicity In Cellular Models Of Synucleinopathy.. Plos One. 2011, 6:26609. DOI: https://doi.org/10.1371/journal.pone.0026609
Shenton Me, Hamoda Hm, Schneiderman Js: Et Al.. A Review Of Magnetic Resonance Imaging And Diffusion Tensor Imaging Findings In Mild Traumatic Brain Injury. Brain Imaging Behav 2012:137–192. DOI: https://doi.org/10.1007/s11682-012-9156-5
Casstillo-Carranza Dl, Guerrero-Muñozmj: Sengupta U. Tau Immunotherapy Modulates Both Pathological Tau And Upstream Amyloid Pathology In An Alzheimer's Disease Mouse Model.The. Journal of Neuroscience 2015, 35:4857–4868 DOI: https://doi.org/10.1523/JNEUROSCI.4989-14.2015
Downloads
Published
How to Cite
Issue
Section
License
With the licence CC-BY, authors retain the copyright, allowing anyone to download, reuse, re-print, modify, distribute, and/or copy their contribution. The work must be properly attributed to its author.
It is not necessary to ask for further permission from the author or journal board.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.